Concepedia

Youngun Kim

YK

Statistics

Publications

4

Citations

357

H-Index

4

Active since

2019

Affiliations

Korea Advanced Institute of Science and Technology(Current)

Yonsei University

Severance Hospital

Youngun Kim is an author at Korea Advanced Institute of Science and Technology specializing in cancer immunology, checkpoint inhibitor therapy, and immune checkpoint regulation.

ORCID

Publications per year

2019–2023

4

Publications

4

VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers

Chang Gon Kim, Mi Jang, Youngun Kim et al. · Science Immunology · 2019 · 254 citations · Full text

, , +16

Dynamic changes in circulating PD-1+CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer

Chang Gon Kim, Min Hee Hong, Kyung Hwan Kim et al. · European Journal of Cancer · 2020 · 47 citations

, , +17

PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors

Minsuk Kwon, Chang Gon Kim, Hoyoung Lee et al. · Clinical Cancer Research · 2020 · 44 citations · Full text

, , +17

High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma

Youngun Kim, Hannah Yang, Won Suk Lee et al. · Journal of Cancer · 2023 · 12 citations · Full text

, , +12

1–4 of 4